Advanced search
Publication Cover
Postgraduate Medicine Volume 129, 2017 - Issue 6
Submit an article Journal homepage
162
Views
7
CrossRef citations to date
0
Altmetric
Clinical Focus: Clinical Immunology & Infectious Diseases - Original Research

Increased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis

Wei WeiDepartment of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information
,
Lei LiuDepartment of Microbiology and Parasitology, Anhui Key Laboratory of Microbiology and Parasitology, Anhui Medical University, Hefei, ChinaView further author information
,
Zhong-Le ChengDepartment of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information
&
Bo HuDepartment of Pediatrics, the First Affiliated Hospital of Anhui Medical University, Hefei, ChinaCorrespondence[email protected]
View further author information
Pages 605-610 | Received 06 Nov 2016, Accepted 11 Jan 2017, Published online: 25 Jan 2017

References

  • Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol. 2004;61:1613–1615.
  • Boissy AR, Cohen JA. Multiple sclerosis symptom management. Expert Rev Neurother. 2007;7:1213–1222.
  • Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9:520–532.
  • Grattan DR, Kokay IC. Prolactin: a pleiotropic neuroendocrine hormone. J Neuroendocrinol. 2008;20:752–763.
  • Ben-Jonathan N, Mershon JL, Allen DL, et al. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996;17:639–669.
  • Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523–1631.
  • Yong VW. Prospects of repair in multiple sclerosis. J Neurol Sci. 2009;277(Suppl 1):S16–S18.
  • Chikanza IC. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci. 1999;876:119–130.
  • Grinsted L, Heltberg A, Hagen C, et al. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med. 1989;226:241–244.
  • Kira J, Harada M, Yamaguchi Y, et al. Hyperprolactinemia in multiple sclerosis. J Neurol Sci. 1991;102:61–66.
  • Yamasaki K, Horiuchi I, Minohara M, et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med. 2000;39:296–299.
  • Harirchian MH, Sahraian MA, Shirani A. Serum prolactin level in patients with multiple sclerosis: a case control study. Med Sci Monit. 2006;12:CR177–CR180.
  • Heesen C, Gold SM, Bruhn M, et al. Prolactin stimulation in multiple sclerosis–an indicator of disease subtypes and activity? Endocr Res. 2002;28:9–18.
  • Nakken B, Szodoray P. Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins? J Rheumatol. 2010;37:482–484.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
  • Moshirzadeh S, Ghareghozli K, Harandi AA, et al. Serum prolactin level in patients with relapsing-remitting multiple sclerosis during relapse. J Clin Neurosci Title. 2012;19:622–623.
  • Markianos M, Koutsis G, Evangelopoulos ME, et al. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis. J Neuroendocrinol. 2010;22:503–508.
  • Nabavi SM, Koupai SA, Nejati MR, et al. Menstrual irregularities and related plasma hormone levels in multiple sclerosis patients treated with beta interferone. Acta Med Iran. 2008;48:36–41.
  • Heesen C, Schulz H, Schmidt M, et al. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun. 2002;16:282–287.
  • Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res. 1999;25:207–214.
  • Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58:840–846.
  • Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 1996;17:64–102.
  • Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev. 2007;6:537–542.
  • Riskind PN, Massacesi L, Doolittle TH, et al. The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol. 1991;29:542–547.
  • Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain. 1997;120(Pt 6):1067–1076.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.